The Control Layer

The Control Layer

The £1 Pill That Could Transform Cancer Care

How low-dose aspirin halves colorectal cancer recurrence for patients with key genetic mutations

Amer Altaf's avatar
Amer Altaf
Oct 04, 2025
∙ Paid

Why it matters

A single daily tablet costing less than 10p has delivered one of the most remarkable breakthroughs in modern oncology. The ALASCCA trial, published in the New England Journal of Medicine

User's avatar

Continue reading this post for free, courtesy of Amer Altaf.

Or purchase a paid subscription.
© 2026 Amer Altaf · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture